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Abstract
 
The activation of downstream signaling pathways of both T cell receptor (TCR) and interleu-
kin 4 receptor (IL-4R) is essential for T helper type 2 (Th2) cell development, which is central
to understanding immune responses against helminthic parasites and in allergic and autoim-
mune diseases. However, little is known about how these two distinct signaling pathways co-
operate with each other to induce Th2 cells. Here, we show that successful Th2 cell develop-
ment depends on the effectiveness of TCR-induced activation of calcineurin. An inhibitor of
calcineurin activation, FK506, inhibited the in vitro anti-TCR–induced Th2 cell generation in
a dose-dependent manner. Furthermore, the development of Th2 cells was significantly im-
paired in naive T cells from dominant-negative calcineurin A
 
a
 
 transgenic mice, whereas that of
Th1 cells was less affected. Efficient calcineurin activation in naive T cells upregulated Janus ki-
nase (Jak)3 transcription and the amount of protein. The generation of Th2 cells induced in
vitro by anti-TCR stimulation was inhibited significantly by the presence of Jak3 antisense oli-
gonucleotides, suggesting that the Jak3 upregulation is an important event for the Th2 cell de-
velopment. Interestingly, signal transducer and activator of transcription (STAT)5 became
physically and functionally associated with the IL-4R in the anti-TCR–activated developing
Th2 cells that received efficient calcineurin activation, and also in established cloned Th2 cells.
 
In either cell population, the inhibition of STAT5 activation resulted in a diminished IL-4–induced
proliferation. Moreover, our results suggest that IL-4–induced STAT5 activation is required
for the expansion process of developing Th2 cells. Thus, Th2 cell development is controlled by
 
TCR-mediated activation of the Ca
 
2
 
1
 
/calcineurin pathway, at least in part, by modifying the
functional structure of the IL-4R signaling complex.
Key words: crosstalk • calcineurin transgenic • Janus kinase 3 • signal transducer and activator 
of transcription 5 • 
 
antennapedia
 
 peptide
 
Introduction
 
CD4
 
1
 
 helper T cells are divided into two distinct sub-
populations on the basis of their cytokine production pro-
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files (1). Th1 cells produce IL-2, IFN-
 
g
 
, and TNF-
 
b
 
,
whereas Th2 cells produce IL-4, IL-5, IL-6, IL-9, IL-10,
and IL-13 (2–5). Because these cytokines play critical roles
in the regulation of immune responses, the identification
of the molecular mechanisms governing Th development
is essential for understanding the immune responses in in-
fectious diseases and pathogenesis of allergic and autoim- 
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mune diseases. Successful development of Th2 cells re-
quires both differentiation and expansion processes, and
depends on the activation levels of IL-4R–mediated sig-
naling (2–7). Among signaling molecules downstream of
IL-4R, signal transducer and activator of transcription
(STAT)
 
1 
 
6 activation is thought to be critical for the dif-
ferentiation process (8–10), and phosphorylation of insulin
receptor substrate (IRS)-2 is important for proliferation
(11, 12). On the other hand, TCR recognition of antigen
and subsequent activation of TCR-mediated signaling
pathways are also indispensable for both Th1 and Th2 cell
development (2–5). We recently reported that efficient ac-
tivation of the p56
 
lck
 
 (Lck) and Ras/mitogen-activated
protein kinase (MAPK) cascade is crucial for Th2 cell dif-
ferentiation (13, 14). The activation of the Ras/MAPK
cascade appears to act on Janus kinase (Jak)1 to enhance its
kinase activity and improve IL-4R function. In contrast,
Th1 cell differentiation and Th1 cytokine production are
dependent on other MAPK pathways, including c-Jun
NH
 
2
 
-terminal kinase (JNK) and p38, respectively (15–17).
Here, we show that TCR-mediated activation of the
Ca
 
2
 
1
 
/calcineurin (CN) pathway is required for Th2 cell
development. The activation of CN in naive CD4 T cells
induces transcriptional upregulation of Jak3. Moreover,
STAT5 is found to be physically and functionally associated
with the IL-4R complex in the anti-TCR–activated naive
T cells and established cloned Th2 cells. The IL-4–induced
activation of STAT5 appears to play an important role in
the expansion process of the developing Th2 cells. Thus,
the recruitment of Jak3 and STAT5 molecules to the func-
tional IL-4R complex in developing Th2 cells appears to
be crucial for Th2 cell development.
 
Materials and Methods
 
Animals.
 
C57BL/6 (B6), BALB/c, and (B6 
 
3 
 
BALB/c)F1
mice were purchased from CLEA Japan Inc. Anti-OVA–specific
TCR-
 
a
 
/
 
b
 
 transgenic (DO10 Tg) mice (18) were provided by
Dr. Dennis Loh (Nippon Roche Research Center, Kanagawa,
Japan). The dominant-negative (dn)CN A
 
a
 
 transgene was gener-
ated by the PCR method. Five amino acid residues in the phos-
phatase active site (148–152) were deleted, and the resulting con-
struct was ligated into the BamHI cloning site of the p1017
vector (19). Overexpression of dnCN in the T cell hybridoma
diminished the nuclear factor of activated T cells (NFAT) lu-
ciferase activities induced by anti-TCR mAb or PMA plus iono-
mycin stimulation (data not shown). A NotI fragment of this
plasmid was isolated and injected into fertilized eggs of B6, and
three lines of transgenic (Tg) mice were established. The Tg
mouse line used in this report (no. 28) expresses 
 
z
 
50 copies of
the transgene. All mice used in this study were maintained under
specific pathogen-free conditions.
 
T Cell Purification and Th1/Th2 Cell Differentiation In Vitro.
 
Naive (CD44
 
low
 
) CD4 T cells from the spleen were prepared by
panning with anti-CD8 (53-6-72) and anti-CD44 (IM7) mAbs as
described (14). Contamination by memory CD44
 
high
 
 CD4 T cells
and CD8 T cells was 
 
,
 
3%. The enriched naive CD4 T cells (0.5 
 
3
 
10
 
6
 
) were stimulated for 2 d with immobilized anti-TCR (H57-
597, 30 
 
m
 
g/ml) or PMA (1 ng/ml) plus ionomycin (100 or 300
nM) in the presence of IL-2 (25 U/ml) and IL-4 (100 U/ml;
Th2-skewed condition) or IL-2 (25 U/ml), IL-12 (1 U/ml), and
anti–IL-4 mAb (11B11, 12.5% culture supernatant; Th1-skewed
condition). The cells were then cultured with only cytokines for
another 3 d. In the DO10 Tg mouse system, naive (CD44
 
low
 
)
CD4 T cells were isolated by a FACSVantage™ cell sorter (Bec-
ton Dickinson), yielding purity of 
 
.
 
98%, and 1.5 
 
3 
 
10
 
4
 
 sorted
CD44
 
low 
 
CD4 T cells were stimulated with antigenic OVA pep-
tide (0.1–1 
 
m
 
M) and irradiated BALB/c APCs (10
 
5
 
) in the pres-
ence of IL-4 (100 U/ml) or IL-12 (0.1 U/ml) for 5 d (14). For
IL-12–induced Th1 cell generation, anti–IL-4 mAb was added.
Intracellular staining of IL-4 and IFN-
 
g
 
 was performed as de-
scribed (14).
 
Immunofluorescent Staining and Flow Cytometry Analysis.
 
In
general, 10
 
6
 
 cells were incubated on ice for 30 min with the ap-
propriate staining reagents using a standard method, as described
previously (14). The cells were incubated with FITC-labeled
anti-CD44 mAb (IM7; BD PharMingen), anti–IL-4R
 
a
 
 mAb
(Genzyme), or anti–common 
 
g
 
 mAb (4G3; BD PharMingen)
followed by anti–rat Ig-FITC. Then, the cells were stained with
anti-CD4–PE (GK1.5-PE; BD PharMingen) after blocking resid-
ual reactive sites of the anti–rat Ig-FITC with a normal rat serum.
Flow cytometry (FCM) analysis was performed on a FACSort™
(Becton Dickinson), and results were analyzed using CELL-
Quest™ software (Becton Dickinson).
 
Immunoprecipitation and Immunoblotting.
 
Naive CD4 T cells
from (B6 
 
3
 
 BALB/c)F1 mice were activated with immobilized
anti-TCR mAb and IL-4 (100 U/ml) for 2 d (induction culture).
Where indicated, FK506 (100 nM) was added. Immunoprecipita-
tion and immunoblotting were performed as described (14). The
reagents used were antiserum specific for STAT6 and STAT5a
(R&D systems), polyclonal Abs against Jak1, Jak3, and IRS-2
(Upstate Biotechnology), or an mAb reactive with IL-4R
 
a
 
(Genzyme). Control Igs used were isotype-matched Igs (BD
PharMingen). In the case of the coprecipitation assay, lysis buffer
without sodium deoxycholate was used. To assess IL-4–induced
tyrosine phosphorylation, stimulated cells were washed, cultured
for 8 h without cytokines, and stimulated with IL-4 (100 U/ml)
for 5 or 10 min at 37
 
8
 
C. Antiphosphotyrosine mAb (RC20;
Transduction Laboratories) was used for detection.
 
Measurement of Phosphatase Activity of CN.
 
Phosphatase activ-
ity was measured by the manufacturer’s protocol supplied in the
CN assay kit (AK-804; BIOMOL Research Laboratories). The
cell lysates of naive CD4 T cells from dnCN A
 
a
 
 Tg (dnCN Tg)
mice and littermate mice were prepared and incubated with
phosphorylated substrate (RII phosphopeptide) at 37
 
8
 
C for 10
min. Then, the amount of released PO
 
4
 
 was determined using
the BIOMOL GREEN™ reagent.
 
Detection of Nuclear Translocation of NFAT.
 
Naive CD4 T
cells were stimulated with immobilized anti-TCR mAb for 2 d,
and nuclear extracts were prepared with a NE-PER™ Nuclear
and Cytoplasmic Extraction Reagent (No. 78833; Pierce Chemi-
cal Co.) according to the manufacturer’s protocol. The amounts
of NFATc1 and NFATc2 in the nuclear extracts were assessed by
immunoblotting with anti-NFATc1 or anti-NFATc2 mAb (BD
PharMingen) as described (20).
 
1
 
Abbreviations used in this paper:
 
 B6, C57BL/6; CN, calcineurin; dn, dom-
inant negative; dnCN Tg, dnCN A
 
a 
 
transgenic; DO10 Tg, anti-OVA–
specific TCR-
 
a
 
/
 
b
 
 transgenic; HA, hemagglutinin; IRS, insulin receptor
substrate; FCM, flow cytometry; Jak, Janus kinase; MAPK, mitogen-acti-
vated protein kinase; NFAT, nuclear factor of activated T cells; STAT,
signal transducer and activator of transcription; Tg, transgenic. 
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Proliferation Assay.
 
IL-4-induced proliferative response was
assessed as described (14). The developing Th2 cells and trans-
fected cells were stimulated with graded doses of mouse recombi-
nant IL-4 for 40 h, and 
 
3
 
H was added at the 24-h time point.
 
Reverse Transcription PCR.
 
Total RNA was prepared using
Trizol (GIBCO BRL). Reverse transcription was done using Su-
perscript II (GIBCO BRL). The primers for Jak3 are 5
 
9
 
-ATG-
GCACCTCCAAGTGAGGAGAC-3
 
9
 
 and 5
 
9
 
-CCAAAGCG-
GTGACATGTCTCCAG-3
 
9
 
.
 
Introduction of Jak3 Antisense Oligonucleotide.
 
Antisense oligonu-
cleotide of Jak3 (5
 
9
 
-CTCACTTGGAGGTGCCATGAGTATA-
ACCGT-3
 
9
 
), sense oligonucleotide of Jak3 (5
 
9
 
-ACGGTTATA-
CTCATGGCACCTCCAAGTGAG-3
 
9
 
), and a scrambled oligo-
nucleotide (5
 
9
 
-GAGGCATGATTGACCATATCCCTCACG-
GTA-3
 
9
 
) were coupled to 16 amino acid–long polypeptides cor-
responding to the third helix of the homeodomain of 
 
antennapedia
 
(Penetratin™; Appligene), which has an activity of plasma mem-
brane penetration (21), according to the manufacturer’s protocol.
1 
 
m
 
M of each oligonucleotide was added to the in vitro differen-
tiation culture system. No toxic effect on T cells was noted in this
condition (data not shown).
 
Transfection of Dominant-negative STAT5 in Th2 Cloned Cells.
 
A Th2 clone D10.G4.1 (D10 [22]) expresses substantial amounts
of both IL-4R
 
a
 
 and STAT5a (data not shown). Hemagglutinin
(HA)-tagged wild-type sheep STAT5 cDNA and Y694F mutant
of STAT5 (dnSTAT5, which can inhibit the activation of both
STAT5a and STAT5b) were provided by Dr. Wakao (Helix Re-
search Institute, Chiba, Japan; reference 23). For the transient as-
say, pEGFP vector (2.5 
 
m
 
g; CLONTECH Laboratories, Inc.) was
cotransfected with 10 
 
m
 
g of STAT5 cDNA ligated into pCR3.1
vector, and 24 h later, green fluorescent protein–positive cells
were sorted by a cell sorter and used in the proliferation assay. For
establishing stable transfectants, plasmid (10 
 
m
 
g) was transfected
by electropolation, and selection was performed in a medium
containing G418 (500 
 
m
 
g/ml; Calbiochem) and IL-2 (5 U/ml).
Expression level of the transfected gene were assessed by immu-
noblotting with anti-HA Ab (Boehringer). In these transfectants,
an equivalent expression level of IL-4R
 
a
 
 to that of D10 cells was
detected (data not shown).
 
Introduction of STAT5 Phosphopeptide in Naive T Cells.
 
A syn-
thetic peptide containing murine STAT5b phosphopeptide (693–
708, inhibiting the activation of both STAT5a and STAT5b; data
not shown) and a 16 amino acid–long polypeptide corresponding
to the third helix of the homeodomain of 
 
antennapedia
 
 (Penetra-
tin™; RQIKIWFPNRRMKWKKAKAADGYpVKPQIKQVV)
was generated. According to previous reports (21, 24–26), 30 or
100 
 
m
 
M of the phospho-STAT5–
 
antennapedia
 
 peptide was added
to the in vitro Th1/Th2 cell differentiation culture system. No
significant toxic effect in T cells was noted in these conditions
(data not shown).
 
Results and Discussion
 
Activation of the Ca
 
2
 
1
 
/CN Pathway and the Generation of
Th1/Th2 Cells In Vitro.
 
The goal of this study is to clarify
how TCR-induced activation of the Ca
 
2
 
1
 
/CN pathway
regulates Th1/Th2 cell development. We initiated the
study by assessing the effect of calcium ionophore on Th1/
Th2 cell development using an in vitro differentiation cul-
ture system. Purified naive CD4 T cells (1.5 
 
3 
 
10
 
6
 
) from
normal (B6 
 
3 
 
BALB/c)F1 mice were stimulated with a
minimum dose of PMA (1 ng/ml) and various concentra-
 
tions of ionomycin. Th1/Th2 cell development was as-
sessed in the presence of 100 U/ml of IL-4 (Th2 skewed)
and 1 U/ml of IL-12 and anti–IL-4 (Th1 skewed). As
shown in Fig. 1 A (top), IL-4–producing Th2 cells were
generated in an ionomycin dose–dependent manner. The
absolute number of Th2 cells generated, which was calcu-
lated from the percentages of Th2 cells and the yield of
harvested cells, was increased 
 
z
 
7 times with 100 nM of
ionomycin, and 
 
.
 
35 times with 300 nM ionomycin in this
experiment. In contrast, the generation of Th1 cells in the
Th1-skewed conditions was not dramatically enhanced,
with an increase of 
 
z
 
1.6 times at best in the presence of ei-
ther 100 or 300 nM of ionomycin (Fig. 1 A, bottom).
Concurrently, the effect of FK506, a specific inhibitor of
CN, was examined on naive T cells cultured with immobi-
lized anti-TCR and IL-4 (Th2 skewed) and with immobi-
lized anti-TCR, IL-12, and anti–IL-4 (Th1 skewed) in the
presence of graded doses of FK506. A dose-dependent de-
crease in the generation of Th2 cells was observed (Fig. 1
B, top). The absolute number of Th2 cells generated in the
presence of 100 nM of FK506 was 
 
z
 
25 times less than that
of control in this experiment. The generation of IFN-
 
g
 
–
producing Th1 cells was decreased significantly, but the
level of the decrease was only about fourfold even in 100
nM FK506. In the presence of FK506, the proportion of
cells that divided at certain times was assessed using carboxy-
fluorescein diacetate succinimidyl ester (CFSE)-labeled na-
ive T cells, and a significant blocking effect on cell division
was observed (data not shown). These results suggest that
the generation of Th2 cells requires the activation of the
Ca
 
2
 
1
 
/CN signaling pathway, and that Th1 and Th2 cell
differentiation exhibits differential dependence on activa-
tion of the Ca
 
2
 
1
 
/CN pathway.
 
Establishment of dnCN Tg Mice.
 
To further investigate
the role of CN activation on Th2 cell development, Tg
mouse lines expressing catalytically inactive CN A
 
a
 
 (dnCN)
under the control of 
 
lck
 
-proximal promoter were estab-
lished. CN A
 
a
 
–deficient mice established by another group
(27) were found not to be suitable for our purpose, as there
are three isoforms in CN Aa molecule, and CN activity
was not abrogated in the CN Aa–deficient mice. In our
dnCN Tg lines, no detectable impairment in T cell devel-
opment in the thymus was observed, as evidenced by
equivalent numbers of thymocytes, normal CD4/CD8
profiles (Fig. 2 A), and TCR Vb usage (data not shown)
compared with control littermates. Similar numbers of na-
ive (CD44low) CD4 T cells were detected in the spleen
(Fig. 2 B). The expression levels of IL-4R complex (IL-
4Ra and common g) and IL-4–induced STAT6 phosphor-
ylation in naive CD4 T cells were not affected (Fig. 2, B
and C). However, the amount of CN Aa protein in the
naive CD4 T cells was increased about twofold (Fig. 2 D),
and there was a substantial decrease in the level of CN
phosphatase activity detected in the dnCN Tg naive CD4
T cells (Fig. 2 E). Consequently, nuclear translocation of
NFATc1 and NFATc2, which is thought to be a result of
CN activation, was assessed in dnCN Tg naive CD4 T cells
after anti-TCR activation. Significant decreases in the1872 Requirement for Calcineurin Activation in Th2 Cell Development
amount of either NFATc were detected (Fig. 2 F). Multi-
ple bands in the NFAT immunoblot may represent differ-
entially glycosylated molecules (28). Consistent with these
results, a slight but significant decrease in the TCR-induced
proliferation and IL-2 production of the dnCN Tg naive T
cells was noted (data not shown).
Requirement for the Activation of CN in Th2 Cell Develop-
ment. The development of Th1 and Th2 cells from naive
CD4 T cells of the dnCN Tg mice was assessed using stim-
ulation with PMA plus ionomycin or immobilized anti-
TCR mAb in either Th2-skewed (Fig. 3 A) or Th1-skewed
(Fig. 3 B) conditions. As expected, a transgene dose–depen-
dent reduction of Th2 cell generation was observed in
dnCN Tg mice in the Th2-skewed condition (Fig. 3 A).
Contrary to the generation of Th2 cells, Th1 cell genera-
tion of dnCN Tg T cells was not significantly impaired in
either Th2-skewed (Fig. 3 A) or Th1-skewed (Fig. 3 B)
conditions. The absolute numbers of the cells harvested
were similar in these cultures (data not shown). Next, the
dnCN Tg mice (B6 background) were crossed with an
OVA-specific TCR-a/b DO10 Tg mouse line (BALB/c
background) in order to determine the effect of the pres-
ence of dnCN on antigenic peptide-induced Th1/Th2 cell
development. As shown in Fig. 3 C (left), the peptide-
induced Th2 cell development was significantly reduced in
the cultures of dnCN Tg compared with littermate controls
(13.1% vs. 25.2%). Similarly, the generation of Th2 cells in-
duced by a minimal dose of antigenic peptide (0.1 mM),
and exogenous IL-4 (100 U/ml) was also impaired (Fig. 3
C, middle). However, no significant reduction was detected
in IL-12–induced Th1 cell differentiation (Fig. 3 C, right).
The considerable inhibiting effects that result from modest
expression of the dnCN Tg suggest that the activation of
CN is required for the development of Th2 cells, whereas
Th1 cell development shows less dependence.
CN-dependent Increase in the Expression of Jak3 in the Anti-
TCR–activated CD4 T Cells. IL-4 treatment of naive T
cells without TCR ligation does not induce Th2 cells (2–
5), and the signal-transducing ability of the IL-4R is ele-
vated in Th2 cells compared with that of naive T cells or
Th1 cells (6, 7). Consequently, we examined whether
TCR-mediated CN activation induced qualitative changes
in the IL-4R signaling complex in developing Th2 cells.
Naive CD4 T cells were stimulated with immobilized anti-
TCR mAb and 100 U/ml of IL-4 for 2 d (induction cul-
ture), and the expression levels of Jak3, Jak1, STAT6, and
IRS-2 protein and Jak3 mRNA were measured (Fig. 4 A).
Interestingly, the expression levels of Jak3 protein and
Figure 1. Activation of the Ca21/CN
pathway and the generation of Th1/Th2
cells in vitro. (A) Naive (CD44low) CD4 T
cells from (B6 3 BALB/c)F1 mice were
stimulated with indicated doses of ionomy-
cin plus PMA (1 ng/ml) in the presence of
IL-4 (100 U/ml; Th2-skewed condition) or
in the presence of anti–IL-4 mAb and IL-12
(1 U/ml; Th1-skewed condition). (B) Na-
ive (CD44low) CD4 T cells from (B6 3
BALB/c)F1 mice were stimulated with im-
mobilized anti-TCR mAb plus IL-4 (100
U/ml; Th2-skewed) or immobilized anti-
TCR mAb plus IL-12 (1 U/ml) and anti–
IL-4 (Th1-skewed) in the presence of vari-
ous doses of FK506. Control represents a
culture in the absence of FK506. The cul-
tured cells were subjected to intracellular
staining with anti–IL-4 and anti–IFN-g.
The numbers of the cells harvested (yield)
are shown as boxed numbers. The percent-
ages of cells in each quadrant are also
shown. The estimated cell numbers of Th2
cells (calculated from the percentages of
Th2 cells and the yield of harvested cells) in
A (top) are 0.05 3 106, 0.35 3 106, and
1.77 3 106 from left to right. The estimated
cell numbers of Th1 cells in A (bottom) are
3.07 3 106, 4.82 3 106, and 4.78 3 106.
Likewise, Th2 cells in B (top) are 2.40 3
106, 1.79 3 106, 0.40 3 106, 0.09 3 106,
respectively, and Th1 cells in B (bottom)
are 6.30 3 106, 6.91 3 106, 2.50 3 106, and
1.60 3 106, respectively.1873 Yamashita et al.
Figure 2. Decreased CN phosphatase activity in naive CD4 T cells of
dnCN Tg mice. (A) Representative CD4/CD8 profiles of thymocytes and
splenocytes from 6-wk-old control littermate (LM) and heterozygous
dnCN Tg1/2 mice are shown. The yield of thymocytes (Thy.) and spleno-
cytes (Spl.) in each mouse is shown as a boxed number. The percentages of
cells present in each area are also shown. (B) Cell surface expression of
CD44, IL-4Ra, and common g chain on electronically gated CD41
splenic T cells from control littermate (dashed line) and dnCN Tg1/2 (solid
line) is shown with background stainings (shaded areas). (C) Tyrosine phos-
phorylation of STAT6 in response to IL-4 in naive CD4 T cells from
dnCN Tg1/2 mice. Freshly prepared naive (CD44low) CD4 T cells were
stimulated with IL-4 (100 U/ml) for 5 min, and the tyrosine phosphoryla-
tion status of STAT6 was assessed by immunoblotting with antiphosphotyrosine mAb (RC20). Arbitrary densitometric units are shown under each band.
LM, littermate; circled P, phosphorylated. (D) The amount of CN in the naive CD4 T cells from dnCN Tg1/2 mice was assessed by immunoblottings
with anti-CN Ab. Cell lysates from indicated doses of naive CD4 T cells are loaded in each lane. Arbitrary densitometric units are shown under each band.
LM, littermate. (E) CN phosphatase activity in the naive CD4 T cells from control littermate (LM), dnCN Tg1/2, and dnCN Tg1/1 mice was assessed by
a CN assay kit. Mean CN phosphatase activity with standard deviations is shown. (F) Decreased NFAT nuclear translocation in anti-TCR–activated CD4
T cells from dnCN Tg mice. Naive CD4 T cells (107) from littermate (LM) and dnCN Tg1/2 mice were stimulated for 2 d with immobilized anti-TCR
mAb, and nuclear extracts were prepared. NFAT translocation was examined by immunoblotting with anti-NFATc1 and anti-NFATc2 mAb. The posi-
tions where NFATc1 and NFATc2 migrate are indicated by dots. Three independent experiments were performed, and similar results were obtained. Ar-
bitrary densitometric units (multiple bands are included for NFATc1) are shown.
Figure 3. Requirement for
CN phosphatase activity in Th2
cell development. (A) Transgene
dosage–dependent decrease in
the generation of Th2 cells in
dnCN Tg mice. Naive CD4 T
cells from heterozygous (Tg1/2)
and homozygous (Tg1/1) dnCN
Tg and control littermate (LM)
mice were stimulated with PMA
(1 ng/ml) plus ionomycin (100
nM) or immobilized anti-TCR
mAb and IL-4 (Th2-skewed
condition), and the generation of
Th1/Th2 cells was assessed. The
absolute numbers of the cells har-
vested were similar in these cul-
tures. (B) Normal Th1 cell de-
velopment in dnCN Tg mice.
Naive CD4 T cells were stimu-
lated in Th1-skewed conditions,
and the generation of Th1/Th2
cells was assessed. The absolute
numbers of the cells harvested
were similar in these cultures.
(C) FCM-sorted naive CD4 T
cells from DO10 Tg1 3 dnCN
Tg2/2 LM and DO10 Tg1 3 dnCN Tg1/2 mice were stimulated with indicated doses of antigenic peptide and APCs (left) or a minimal dose of peptide
(0.1 mM) and APCs in the presence of exogenous IL-4 (middle) or IL-12 and anti–IL-4 mAb (right).1874 Requirement for Calcineurin Activation in Th2 Cell Development
mRNA were increased about three- to fourfold in the acti-
vated T cells, and this increase was almost completely
blocked by the presence of FK506. Increase in Jak3 protein
was also detected in the cells stimulated with PMA plus
ionomycin but not with PMA alone. In contrast, the level
of Jak1 protein was not changed by TCR stimulation, and
the levels of STAT6 and IRS-2 were increased signifi-
cantly and partially inhibited by FK506. The cell surface
expression levels of IL-4Ra were increased significantly by
the induction culture with anti-TCR and IL-4, and these
were not significantly affected by the presence of FK506
(Fig. 4 B). This result is consistent with our previous re-
port, where IL-4Ra upregulation is induced by IL-4 in
naive T cells (14). On the other hand, the upregulation of
common g appeared to be slightly lower in the cells cul-
tured with FK506, but the level of upregulation was
within minimal levels, and these results are therefore diffi-
cult to interpret. In addition, the number of functional
binding sites of IL-4 also appears equivalent in the anti-
TCR–activated T cells in the presence or absence of
FK506, as reflected by the equivalent binding of iodinated
IL-4 (data not shown).
Improvement of IL-4R Function in the Anti-TCR–activated
T Cells Is Dependent on CN Activation. Concurrently, IL-
4R function was assessed by measurement of the IL-4–
induced tyrosine phosphorylation on Jak1, Jak3, STAT6,
and IRS-2. As expected, IL-4–induced phosphorylation of
these signaling molecules was dramatically enhanced in the
activated T cells with anti-TCR and IL-4 (14), and the en-
hancement was significantly inhibited by FK506, suggesting
CN dependence (Fig. 4 C). Jak1 and Jak3 are known to
phosphorylate to each other, and STAT6 and IRS-2 can be
phosphorylated by both Jak1 and Jak3 (29). Together with
the results shown in Fig. 4 A, the CN-dependent enhance-
ment in the IL-4–induced phosphorylation of Jak1 and
Jak3 may be due to the increase in the amount of Jak3 pro-
tein. The enhanced STAT6 and IRS-2 phosphorylation
may be the result of the increased activation of Jak1 and
Jak3, as well as increased protein levels of STAT6 and IRS-2.
The improved IL-4R function in the activated T cells
Figure 4. The increase in Jak3 expression and improvement of IL-4R function are dependent on CN activation. (A) Naive CD4 T cells were stimu-
lated with immobilized anti-TCR mAb and IL-4 for 2 d in the presence or absence of FK506. The expression levels of the indicated molecules were as-
sessed by immunoprecipitation and immunoblotting with specific Abs. To detect mRNA levels of Jak3, reverse transcription PCR analysis was per-
formed with a specific primer. Arbitrary densitometric units are shown under each band. (B) Cell surface expression of IL-4Ra and common g chain of
the stimulated cells, as in A. The background stainings are shown by shaded areas. (C) Naive CD4 T cells were stimulated for 2 d as in A, and IL-4–induced
phosphorylation on the indicated molecules was assessed. Arbitrary densitometric units are shown under each band. Circled P, phosphorylated. (D) The
cells stimulated for 2 d as in C were cultured without anti-TCR stimulation for another 8 h, and IL-4–induced proliferative response was assessed. Mean
[3H]thymidine incorporation in each culture is shown with standard deviations.1875 Yamashita et al.
was seen in the IL-4–induced proliferative responses, where
dramatic CN-dependent improvement was observed (Fig. 4
D, left). Likewise, stimulation with PMA plus ionomycin
but not PMA alone induced a similar improvement in the
IL-4–induced proliferation (Fig. 4 D, right).
Inhibition of Th2 Cell Development by the Presence of an
Antisense DNA of Jak3. The Drosophila antennapedia homeo-
domain protein peptide (Penetratin™) is reported to pene-
trate mammalian plasma membranes and to work as a vec-
tor for oligonucleotides or short peptides (21, 24–26). We
used this system to deliver Jak3 antisense oligonucleotide to
assess the requirement for transcriptional upregulation of
Jak3 in Th2 cell development. As shown in Fig. 5 A, the
introduction of Jak3 antisense oligonucleotide into naive T
cells inhibited the Th2 cell generation significantly, sug-
gesting that the upregulation of Jak3 protein is an impor-
tant event for the Th2 cell development. Immunoblotting
with anti-Jak3 mAb revealed that the level of Jak3 protein
in the activated cells with Jak3 antisense was z60% of the
control level (Fig. 5 B). The blocking effect on Th2 cell
development was not observed by the presence of Penetra-
tin™-coupled control oligo DNAs such as a Jak3 sense or a
scrambled oligo DNA (Fig. 5 C).
Involvement of STAT5 Activation in IL-4–induced Prolifera-
tion and Th2 Cell Development. STAT5 is a well-known
downstream signaling molecule of a wide variety of cyto-
kine receptors, including IL-2R, IL-7R, IL-9R, and IL-15R,
and an important role for STAT5 in proliferative responses
has been suggested (30–34). Although the four receptors
and IL-4R share common g and Jak3, STAT5 has not been
established as a downstream signaling molecule of IL-4R.
However, in the activated T cells with anti-TCR and IL-4,
IL-4-stimulation (10 min) induced phosphorylation of
STAT5a molecules, and this phosphorylation was signifi-
cantly inhibited by FK506 in the induction culture (Fig. 6
A, left). No phosphorylation was detected in the immuno-
precipitates with control Ig. The other STAT5 isoform,
STAT5b, was also phosphorylated by the 10-min IL-4
stimulation (data not shown). Although significantly lower,
considerable levels of IL-4–induced STAT5 phosphoryla-
tion were detected even in the activated cells with anti-
TCR mAb in the presence of anti–IL-4 and IL-12 (a Th1-
skewed condition; Fig. 6 A, right), suggesting that the
functional association of STAT5 to the IL-4R complex is
not specific for the Th2-skewed stimulation condition, but
is a TCR-mediated consequence.
Simultaneously, we sought evidence for a physical asso-
ciation of STAT5a with IL-4R. As can be seen in Fig. 6 B,
STAT5a molecules were coprecipitated with IL-4Ra in
the anti-TCR–activated T cells but not in naive T cells,
and this association was dependent on CN activation. In-
terestingly, this STAT5a association with IL-4Ra appears
not to be dependent on the short-term IL-4 stimulation (10
min). Again, isotype-matched control Ig did not precipitate
Figure 5. Inhibition of Jak3 induction by antisense oligonucleotide results in a decreased Th2 cell generation. The effect of Jak3 antisense, sense, or
scrambled oligonucleotide coupled with Penetratin™ was assessed in the in vitro Th1/Th2 cell differentiation culture (Th2-skewed condition). Stimula-
tion with immobilized anti-TCR and indicated doses of (A) IL-4 or (C) anti-TCR and 1 U/ml of IL-4 were used. The protein expression levels of Jak3
in the cells shown in A (1 U/ml of IL-4) were assessed by immunoprecipitation and immunoblotting with anti-Jak3 mAb (B).1876 Requirement for Calcineurin Activation in Th2 Cell Development
either STAT5a or IL-4Ra. Consistent with the results by
FCM analysis (Fig. 4 B), the upregulation of IL-4Ra mol-
ecule was not significantly blocked by the presence of
FK506 (Fig. 6 B, bottom). These results indicate that
STAT5 molecules are physically and functionally associated
with the IL-4R complex in the anti-TCR–activated T cells
receiving sufficient CN activation. Consistent with our re-
sults, IL-4–induced STAT5 activation has been recently re-
ported in a certain B cell line and in PHA-activated human
peripheral blood cells (35), and IL-4–induced proliferation
was impaired in STAT5-deficient spleen cells (36).
To investigate the role of STAT5 activation in develop-
ing Th2 cells, we generated a fusion peptide comprising
STAT5 phosphopeptides and antennapedia peptides (Pene-
tratin™; phospho-STAT5–antennapedia peptide) to inhibit
STAT5 dimerization and activation. IL-4–induced prolif-
eration of developing Th2 cells was assessed in the presence
of the phospho-STAT5–antennapedia peptide, and signifi-
cant blocking effects were detected (Fig. 6 C). The addi-
tion of a nonphosphorylated control peptide did not affect
the IL-4–induced proliferation, suggesting a phospho-
STAT5 peptide–dependent phenomenon. When the phos-
pho-STAT5–antennapedia peptide was added to the in vitro
Th2 cell differentiation cultures (Th2-skewed condition), a
similar blocking effect on the development of Th2 cells was
observed (Fig. 6 D). The levels of absolute number of Th2
cells generated are at z60% with 30 mM and z3% with
100 mM of the phospho-STAT5. Thus, the IL-4–induced
activation of STAT5 appeared to be crucial in the expan-
sion of developing Th2 cells.
Constitutive Association of STAT5 with IL-4R Complex in
Cloned Th2 Cells. Finally, to investigate the role of
STAT5 activation for IL-4–induced proliferation in an es-
tablished Th2 cell clone, an IL-4–responding Th2 clone
D10 (22) was transfected with a (dn)STAT5 cDNA (23). In
the parent D10 T cell clone, a dose-dependent induction
of the IL-4–induced STAT5 phosphorylation was detected
(Fig. 7 A). In addition, the constitutive association of
STAT5a molecules with IL-4Ra was observed (Fig. 7 B).
Similar to anti-TCR–activated CD4 T cells (Fig. 6 B), the
STAT5a association in D10 clone did not appear to be de-
pendent on the short-term IL-4 exposure (10 min, 10 U/
ml). Analysis of transiently transfected D10 cells and three
independent stable transfectants with an HA-tagged
dnSTAT5 revealed a significant impairment in IL-4–induced
proliferation (Fig. 7 C). The association of transfected
dnSTAT5 protein in the transient transfected D10 cells was
confirmed by immunoblotting with anti-HA mAb (Fig. 7
D, left). In addition, IL-4–induced phosphorylation of
STAT5a molecules was not detected in the stable transfec-
tants (Fig. 7 D, right) and transient transfectants with
dnSTAT5 (data not shown). Collectively, these data sug-
gest that IL-4–induced proliferation of D10 clone is
strongly dependent on STAT5 activation.
The Strength of TCR Stimulation and Th1/Th2 Cell Devel-
opment. In this report, we demonstrate that TCR-mediated
activation of Ca21/CN is required for Th2 cell develop-
ment, and a differential dependence on the CN activation
between Th1 and Th2 cell development is revealed. Sev-
eral recent reports suggested that low-dose infection or
Figure 6. Requirement for
STAT5 activation in IL-4–induced
expansion of developing Th2
cells. (A) IL-4–induced phosphor-
ylation of STAT5a molecules
were examined in the anti-TCR-
activated CD4 T cells prepared
as described in the legend to Fig.
4 C. To assess the levels of STAT5
phosphorylation, immunopre-
cipitation (IP) with anti-STAT5a
and subsequent immunoblotting
(Blot) with antiphosphotyrosine
(p-Tyr) were performed. An iso-
type-matched Ab was used for
the control immunoprecipita-
tion. For a control, immunoblot-
ting with anti-STAT5a was also
performed. In experiment (Exp.)
2, naive T cells were activated
for 2 d with anti-TCR and IL-4
or with anti-TCR, anti-IL-4,
and IL-12, and were subjected to
STAT5 immunoprecipitation.
(B) To detect STAT5a associa-
tion with IL-4Ra, immunoprecipitates with anti–IL-4Ra were subjected to immunoblotting (Blot) with anti-STAT5a and anti–IL-4Ra. An isotype-
matched Ab was used for the control immunoprecipitation (IP). Arbitrary densitometric units are shown under each band. (C) IL-4–induced proliferation
of anti-TCR–activated developing Th2 cells as shown in A, was assessed in the presence of indicated doses of phospho-STAT5–antennapedia peptide or
nonphosphorylated control peptide. The mean [3H]thymidine incorporation of each group is shown with standard deviations. (D) The effect of the phos-
pho-STAT5–antennapedia peptide on Th2 cell development in vitro. Naive CD4 T cells from (B6 3 BALB/c)F1 mice were stimulated with immobilized
anti-TCR mAb and IL-4 in the presence of indicated doses of phospho-STAT5–antennapedia peptide. The numbers of the cells harvested are shown as
boxed numbers. The percentages of cells in each quadrant are also shown. The estimated cell numbers of Th2 cells generated are 2.23 3 106, 1.29 3 106,
and 0.07 3 106 from left to right.1877 Yamashita et al.
low-dose antigen concentration induced Th1 responses
preferentially, whereas high-dose antigen stimulation fa-
vored Th2 responses (37–39). We reported previously that
strong activation of Lck and subsequent activation of the
Ras/MAPK pathway was required for Th2 cell differentia-
tion (13, 14). Taken together with the findings shown in
this report, strong stimulation of naive CD4 T cells may
sufficiently activate Lck and downstream signaling path-
ways, including the Ras/MAPK and Ca/CN pathways,
and induce Th2 cell development. In contrast, weak anti-
genic stimulation may not activate these signaling pathways
efficiently enough for Th2 cell development, but may be
sufficient for Th1 development. Thus, the extent to which
both Ras/MAPK and Ca21/CN pathways are activated
may determine the Th1/Th2 cell lineage into which naive
CD4 T cells will develop.
Functional IL-4R Complex in Developing Th2 Cells. Af-
ter anti-TCR activation of naive CD4 T cells, the expres-
sion levels of various components of the IL-4R complex are
upregulated, and the function of IL-4R is improved dra-
matically. Among them, Jak3 upregulation was most dra-
matic and appeared to be totally dependent on TCR-medi-
ated CN activation. The upregulation of STAT6, STAT5a,
and IRS-2 molecules was partially CN dependent. In con-
trast, little dependency on CN activation was observed in
the upregulation of IL-4Ra (Fig. 4 B and Fig. 6 B). In fact,
the upregulation of IL-4Ra is shown to be induced by IL-4
itself (14). Although of interest, the molecular mechanisms
governing IL-4–induced IL-4Ra upregulation have not
been well elucidated at this time. The inhibition of the Jak3
upregulation by antisense Jak3 resulted in a diminished Th2
cell development (Fig. 5), suggesting that the Jak3 upregu-
lation is an important event for Th2 cell development.
Therefore, although transcriptional upregulation of other
CN/NFAT–dependent molecules may also be required for
the Th2 cell development, this study strongly suggests that
one of the important targets is Jak3.
Interestingly, STAT5 was found to be physically and
functionally associated with IL-4R complex in the anti-
TCR–activated T cells (Fig. 6). The IL-4–induced activa-
tion of STAT5 appears to be crucial for the expansion process
of developing Th2 cells (Fig. 6, C and D). Interestingly, the
STAT5 association is maintained in established cloned Th2
cells (Fig. 7, A and B). This may be the reason why some
Th2 cell clones can proliferate to IL-4 as well as to IL-2.
Although the precise molecular basis by which STAT5 as-
sociates with IL-4R complex remains unclear, the associa-
tion is probably mediated by Jak3, because STAT5 associa-
tion was detected only after Jak3 upregulation (Fig. 4 A and
Fig. 6, A and B). A possible mechanism for the interaction
of these two molecules has been proposed by other investi-
gators (35, 40). Alternatively, STAT5 may be recruited to
Jak1 associated with IL-4Ra. This possibility is also sug-
gested in the IL-6R system (40). In addition, it is not clear
whether the STAT5 association is a phosphorylation-depen-
dent phenomenon or not. Further comprehensive biochem-
ical analyses are required to address this issue.
In addition to STAT5 activation, it can be speculated
that the CN-dependent Jak3 upregulation also facilitates
IL-4–induced activation of STAT6 and IRS-1 and -2,
Figure 7. Requirement for STAT5 activation in IL-4–induced prolif-
eration in cloned Th2 cells. (A) IL-4–induced STAT5a phosphorylation
was assessed in a Th2 clone D10. D10 cells were stimulated with indi-
cated doses of IL-4 for 10 min, and tyrosine phosphorylation status of
STAT5a was assessed by immunoprecipitation (IP) with anti-STAT5a
and subsequent immunoblotting (Blot) with antiphosphotyrosine (p-Tyr).
As a control, immunoblotting with anti-STAT5a was also performed. (B)
Association of STAT5a with IL-4Ra was assessed in a Th2 clone D10.
IP, immunoprecipitation; Blot, immunoblotting. (C) IL-4–induced pro-
liferative responses of transient (left) and stable (right) transfectants with
dnSTAT5. The data from parent D10 (s), a stable transfectant with wild-
type STAT5 (h), and a transient and three independent stable transfec-
tants with dnSTAT5 (d, m, r) are shown. (D) dnSTAT5 association
with IL-4Ra complex and lack of STAT5a phosphorylation in the tran-
sient dnSTAT5-transfected D10 cells. The association of transfected HA-
tagged STAT5 Y694F mutant (dnSTAT5) molecules with IL-4Ra was
assessed by immunoprecipitation (IP) with anti-IL-4Ra and immuno-
blotting (Blot) with anti-HA Ab. p-Tyr, antiphosphotyrosine.1878 Requirement for Calcineurin Activation in Th2 Cell Development
which are thought to be important for differentiation and
expansion processes, respectively (29). In fact, the protein
expression levels of STAT6 and IRS-2 were also upregu-
lated in the anti-TCR–activated naive CD4 T cells (Fig. 4
A). Thus, successful development of Th2 cells appears to
depend on cooperative events that involve IL-4–mediated
activation of STAT5- as well as of STAT6- and IRS-medi-
ated signaling pathways, and it is clearly influenced and
regulated by antigen receptor–mediated signaling cascade,
such as the Ras/MAPK pathway (14) and the Ca21/CN
signaling pathway.
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